tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BIOA Stock Latest News

BioAge Labs Advances Clinical Programs Amid Financial Progress
Company AnnouncementsBioAge Labs Advances Clinical Programs Amid Financial Progress
5d ago
BIOA
BioAge Labs price target raised to $15 from $10 at Citi
PremiumThe Fly
BioAge Labs price target raised to $15 from $10 at Citi
14d ago
BIOA
Citi upgrades BioAge Labs to Buy on potential in obesity
PremiumThe Fly
Citi upgrades BioAge Labs to Buy on potential in obesity
21d ago
BIOA
BioAge Labs upgraded to Buy from Neutral at Citi
PremiumThe Fly
BioAge Labs upgraded to Buy from Neutral at Citi
21d ago
BIOA
BioAge Labs files to sell 2.23M shares of common stock for holders
PremiumThe Fly
BioAge Labs files to sell 2.23M shares of common stock for holders
1M ago
BIOA
BioAge Labs files $250M mixed securities shelf
PremiumThe FlyBioAge Labs files $250M mixed securities shelf
1M ago
BIOA
BioAge Labs announces first participant dosed in Phase 1 trial of BGE-102
Premium
The Fly
BioAge Labs announces first participant dosed in Phase 1 trial of BGE-102
3M ago
BIOA
BioAge Labs Reports Q2 2025 Financial Results and Progress
Premium
Company Announcements
BioAge Labs Reports Q2 2025 Financial Results and Progress
3M ago
BIOA
Cautious Outlook on BioAge Labs, Inc. Amid Uncertainties in Clinical Developments and Market Perception
PremiumRatings
Cautious Outlook on BioAge Labs, Inc. Amid Uncertainties in Clinical Developments and Market Perception
3M ago
BIOA
BioAge Labs announces it will present new preclinical data on APJ agonism
PremiumThe Fly
BioAge Labs announces it will present new preclinical data on APJ agonism
5M ago
BIOA
BioAge Labs expands drug discovery platform with data from HUNT Biobank
PremiumThe Fly
BioAge Labs expands drug discovery platform with data from HUNT Biobank
5M ago
BIOA
BioAge Labs Elects Directors at Annual Meeting
PremiumCompany Announcements
BioAge Labs Elects Directors at Annual Meeting
5M ago
8K
BIOA
BioAge Labs Updates Milestones for NLRP3 Program
PremiumCompany AnnouncementsBioAge Labs Updates Milestones for NLRP3 Program
5M ago
8K
BIOA
BioAge Labs expands APJ agonist pipeline with biologic candidates
Premium
The Fly
BioAge Labs expands APJ agonist pipeline with biologic candidates
5M ago
BIOA
BioAge Labs completes IND-enabling studies for BGE-102
Premium
The Fly
BioAge Labs completes IND-enabling studies for BGE-102
6M ago
BIOA
Cautious Outlook on BioAge Labs, Inc. Amid Program Setbacks and Financial Concerns
PremiumRatings
Cautious Outlook on BioAge Labs, Inc. Amid Program Setbacks and Financial Concerns
6M ago
BIOA
BioAge Labs Advances Pipeline with Strategic Collaborations
PremiumCompany Announcements
BioAge Labs Advances Pipeline with Strategic Collaborations
6M ago
BIOA
BioAge Labs price target lowered to $5 from $7 at Citi
PremiumThe Fly
BioAge Labs price target lowered to $5 from $7 at Citi
8M ago
BIOA
Cautious Outlook on BioAge Labs Amid Promising Developments and High Risk
PremiumRatings
Cautious Outlook on BioAge Labs Amid Promising Developments and High Risk
8M ago
BIOA
BioAge Labs, Inc.: Sell Rating Due to Discontinued Program and Uncertain Prospects
PremiumRatingsBioAge Labs, Inc.: Sell Rating Due to Discontinued Program and Uncertain Prospects
8M ago
BIOA
BioAge Labs assumed with an Underweight at Morgan Stanley
Premium
The Fly
BioAge Labs assumed with an Underweight at Morgan Stanley
8M ago
BIOA
Cautious Outlook on BioAge Labs, Inc. Amid Program Discontinuation and Development Risks
Premium
Ratings
Cautious Outlook on BioAge Labs, Inc. Amid Program Discontinuation and Development Risks
8M ago
BIOA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >